» Articles » PMID: 10881988

Adjunctive Risperidone Treatment in Patients with 'clozapine-resistant Schizophrenia'

Overview
Specialty Psychiatry
Date 2000 Jul 6
PMID 10881988
Citations 6
Authors
Affiliations
Soon will be listed here.
Citing Articles

Treatment of the special patient with schizophrenia.

Conley R, Kelly D Dialogues Clin Neurosci. 2011; 3(2):123-35.

PMID: 22034474 PMC: 3181645.


Treatment-refractory schizophrenia.

Caspi A, Davidson M, Tamminga C Dialogues Clin Neurosci. 2011; 6(1):61-70.

PMID: 22034144 PMC: 3181784.


Benefits and risks of antipsychotic polypharmacy: an evidence-based review of the literature.

Tranulis C, Skalli L, Lalonde P, Nicole L, Stip E Drug Saf. 2007; 31(1):7-20.

PMID: 18095743 DOI: 10.2165/00002018-200831010-00002.


Risperidone augmentation of clozapine: a critical review.

Kontaxakis V, Ferentinos P, Havaki-Kontaxaki B, Paplos K, Pappa D, Christodoulou G Eur Arch Psychiatry Clin Neurosci. 2006; 256(6):350-5.

PMID: 16900439 DOI: 10.1007/s00406-006-0643-9.


Augmentation strategies in clozapine-resistant schizophrenia.

Remington G, Saha A, Chong S, Shammi C CNS Drugs. 2005; 19(10):843-72.

PMID: 16185094 DOI: 10.2165/00023210-200519100-00004.